RxDoctor Payments DataLook up a doctor →

Jeffrey Shupp, MD

Surgery · Washington, DCNPI 1972760874

Payments from drug & device makers

$1,238,635in general payments, 2019–2025

Across 429 payments — averaging $2887.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mallinckrodt Hospital Products Inc.$371K
  • Avita Medical Americas, LLC$306K
  • Organogenesis Inc.$120K
  • Polynovo North America LLC$118K
  • Takeda Pharmaceuticals U.S.A., Inc.$115K
  • Mallinckrodt Enterprises LLC$87K
  • plus $121K from 9 others
$3,133in research payments, 2019–2025

Across 12 payments — averaging $261.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Acell, Inc.$2K
  • Takeda Pharmaceuticals U.S.A., Inc.$929

What the payments were for

  • Consulting fees$33,68483%
  • Speaking & faculty fees$5,00012%
  • Food & beverage$1,7314%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,238,635 in reported general payments places this provider in the 95th percentile of 117 surgery providers in District of Columbia.

See all surgery providers in District of Columbia

Medicare billing

Part B allowed, 2024
$40,878
Medicare patients
54
Services billed
371

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other surgery in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →